Home › NCT07164456
Together Stronger: A Family-centered Lifestyle Intervention for Black Prostate Cancer Survivors and Their Caregivers
Recruiting
Who can join
Ages 18 and older · Men
Full eligibility criteria
Eligibility Criteria Survivors are eligible if they * Are adults (≥18 years old) * Self-identify as Black or African American; * Were diagnosed with stage 0-III PCa; completed PCa treatment; (5) are able to be physically active, as determined by responses to the Physical Activity Readiness Questionnaire (PAR-Q); and * Have a family caregiver willing to participate together. Individuals under active surveillance for PCa will be included. Caregivers are eligible if they: * Are adults (≥18 years old) * Are able to be physically active, as determined by responses to the Exclusion Criteria Survivors are excluded if they: * Have a prior history of other cancer or have metastatic cancer. * Have planned concomitant immunotherapy, hormonal therapy, chemotherapy, or radiation therapy during the study period. * Meet physical activity recommendations (i.e., 150 min of moderate intensity physical activity per week); and (4) are currently participating in a lifestyle or weight management program. Caregivers are excluded if they: * Have serious medical conditions (e.g., cancer, congestive heart failure, stroke, and dementia) * Are currently participating in a lifestyle or weight management program.
About the study
To establish the efficacy of the family-centered intervention in improving healthy lifestyle behaviors (MVPA and overall diet quality), as well as physical functioning, QoL, and family health climate, compared to survivor-only and control groups.
What is being tested
- Education sessions (other)
- Questionnaire (other)
Sponsor: M.D. Anderson Cancer Center · Participants: 648 · Started: Jan 13, 2026
Contact the study team
- Dalnim Cho, MD · Phone: 713-745-8476
Official record on ClinicalTrials.gov — NCT07164456
Locations in the U.S.
| Texas | MD Anderson Cancer Center, Houston |
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.